|
Volumn 153, Issue 12, 1996, Pages 1631-1633
|
Double-blinded controlled trial of sertraline versus paroxetine in the treatment of delusional depression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FLURAZEPAM;
LITHIUM;
PAROXETINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
1 NAPHTHYLAMINE;
DRUG DERIVATIVE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DELUSION;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
SYMPTOMATOLOGY;
COMPARATIVE STUDY;
DOSE RESPONSE;
DRUG ADMINISTRATION;
HOSPITALIZATION;
MIDDLE AGED;
PSYCHOLOGICAL ASPECT;
TREATMENT OUTCOME;
1-NAPHTHYLAMINE;
DELUSIONS;
DEPRESSIVE DISORDER;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HOSPITALIZATION;
HUMANS;
MALE;
MIDDLE AGED;
PAROXETINE;
SEROTONIN UPTAKE INHIBITORS;
SERTRALINE;
TREATMENT OUTCOME;
|
EID: 0029658717
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/ajp.153.12.1631 Document Type: Article |
Times cited : (134)
|
References (9)
|